Feb 14, 2018
209:200
For every 200 shares held, investors received 209. The price per share adjusted from $0.51 to $0.49.
The split itself did not change the total investment value.
Crescita Therapeutics, Inc. (CRRTF) trades on the Other OTC in the Drug Manufacturers - Specialty & Generic industry.
Crescita Therapeutics, Inc. company overviewThe latest split shown was on February 14, 2018. It was a 209-for-200 forward split, so shareholders received 209 shares for every 200 they held.
This history records one forward split, on February 14, 2018.
Already premium?